TRIANA Biomedicines
Latest round
- Series B
Last raised
- Nov 2025
Total raised
- $179M
Investors
- 12
About TRIANA Biomedicines
TRIANA Biomedicines, Inc. is dedicated to the discovery and development of therapeutics leveraging its unique molecular glue technology. The company, headquartered in Lexington, US, has navigated strategic pivots to enhance its offerings.TRIANA Biomedicines specializes in the discovery and development of innovative therapeutics through its proprietary molecular glue technology. The company's core product offerings focus on small molecules that enhance protein-protein interactions, forming ternary complexes that can impact disease pathways, particularly in the realm of targeted protein degradation. With an emphasis on cancer treatment, TRIANA aims to address disease targets that have historically been deemed undruggable. The company focuses its efforts in diverse global markets, primarily targeting regions with strong pharmaceutical infrastructures, including North America, Europe, and parts of Asia.TRIANA Biomedicines generates revenue primarily through strategic partnerships and collaborations with pharmaceutical companies and research institutions. These agreements involve licensing its molecular glue technology and co-development of therapeutic candidates. Transactions typically occur through structured collaboration models, where financial terms are based on milestones and outcomes related to drug development. The revenue structure may include upfront payments, milestone payments upon achieving specific clinical or regulatory outcomes, and royalties on future sales of any products developed from these collaborations.In December 2025, TRIANA Biomedicines, Inc. The company plans to select a second product candidate in 2026 and accelerate the development of its pipeline programs.
Who invested in TRIANA Biomedicines
12 investors across 5 rounds
See all investors in TRIANA Biomedicines
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about TRIANA Biomedicines
Who invested in TRIANA Biomedicines?
TRIANA Biomedicines has 12 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TRIANA Biomedicines raised?
TRIANA Biomedicines has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did TRIANA Biomedicines last raise money?
TRIANA Biomedicines's most recent round on record is a Series B, in Nov 2025.
What does TRIANA Biomedicines do?
TRIANA Biomedicines is a biotechnology company.
Where is TRIANA Biomedicines headquartered?
TRIANA Biomedicines is headquartered in Lexington, US.
Which VCs invest in companies like TRIANA Biomedicines?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at TRIANA Biomedicines's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like TRIANA Biomedicines? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.